Furthermore, it was shown that both IFN-β1 overexpression and IFN-α-2b administration in mouse models of high fat diet-induced obesity prevent weight gain and suppress immune cell infiltration into AT, attenuate adipose inflammation, and limit AT expansion [83]. Here, IFNA1 is linked to obesity disorder.